It increases controlled hepatic glucose production, facilitates fat breakdown, and raises resting energy expenditure
If your Medicaid plan wont cover Ozempic, you have several options: 1
Animal studies suggest GLP-1 signaling in the brain may help recalibrate sleep-wake cycles entirely independent of body weight changes, though these findings have not yet been replicated in humans (ref)
Tirzepatide: As a newer option, Tirzepatide targets both GLP-1 and GIP receptors, making it a unique choice for those exploring different weight management solutions
Hence, we strongly encourage the adoption of GLP-1RA plus SGLT2i combination therapy in T2DM patients with uncontrolled metabolic risks, i.e., especially those who need to lose weight and/or control high blood pressure
2018;172(e421):40922